| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/28/2007 | WO2007073186A2 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 06/28/2007 | WO2007073095A1 Process for the preparation of (s)-(+)-clopidogrel on a solid-phase |
| 06/28/2007 | WO2007072971A1 Agent for improving angiopathy containing sulfated polysaccharide derived from green alga and method for producing the same |
| 06/28/2007 | WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME |
| 06/28/2007 | WO2007072902A1 Therapeutic agent for acute cerebral infarct |
| 06/28/2007 | WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv) |
| 06/28/2007 | WO2007072564A1 Remedy/preventive for heart failure |
| 06/28/2007 | WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | WO2007071738A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | WO2007071605A1 The use of st1898 for the treatment of restenosis |
| 06/28/2007 | WO2007071379A1 PYRROLO [l,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF |
| 06/28/2007 | WO2007071357A2 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid |
| 06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | WO2007071069A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements |
| 06/28/2007 | WO2007071038A2 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers |
| 06/28/2007 | WO2007071036A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/28/2007 | WO2007071023A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | WO2007070961A1 Mif inhibitors |
| 06/28/2007 | WO2007016563A3 Alcohol resistant pharmaceutical formulations |
| 06/28/2007 | WO2007014029A3 Yin yang 1 as a treatment for cardiac hypertrophy and heart failure |
| 06/28/2007 | WO2007009529A3 Calcium-peptide component |
| 06/28/2007 | US20070150971 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/28/2007 | US20070149614 Guanidine and amidine acid derivatives and analogs and methods of using the same |
| 06/28/2007 | US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 06/28/2007 | US20070149587 Valsartan Salts |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149571 Combination therapy for treating or managing acute myelocytic leukemia |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/28/2007 | US20070149545 Substituted indan derivatives |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148217 Percutaneous absorption type cerebral protective agent |
| 06/28/2007 | US20070148207 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/28/2007 | US20070148160 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 06/28/2007 | US20070148123 Substances and agents for positively influencing collagen |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis |
| 06/28/2007 | DE102005061655A1 Diazepinone Diazepinones |
| 06/28/2007 | DE102005060880A1 Preparing special extracts, useful as an anti-arrhythmic in cardiac arrhythmia and for the improvement of coronary perfusion, comprises extracting the extracts from aboveground plant parts of the plant Leonurus cardiaca |
| 06/28/2007 | CA2673010A1 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers |
| 06/28/2007 | CA2673005A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/28/2007 | CA2634291A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements |
| 06/28/2007 | CA2634212A1 Mif inhibitors |
| 06/28/2007 | CA2634165A1 Pyrrolo [1,2-a]quinoxaline derivatives as adenosine a3 receptor modulators and uses thereof |
| 06/28/2007 | CA2634158A1 Use of 4, 7-dihydrothieno ¬2, 3-b| pyridine compounds in the treatment of cardiovascular diseases |
| 06/28/2007 | CA2634056A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | CA2633484A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | CA2633331A1 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | CA2632936A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | CA2632400A1 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 06/28/2007 | CA2630704A1 Pharmaceutical composition |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/27/2007 | EP1801193A1 Process for producing concentrate of unsaturated fatty acid |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 06/27/2007 | EP1801111A1 Novel polymorph forms of olmesartan medoxomil |
| 06/27/2007 | EP1800685A1 Steroidal saponin pharmaceutical composition, its preparation method and use |
| 06/27/2007 | EP1800683A1 New association of an If sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association |
| 06/27/2007 | EP1800680A1 Cerebral infarction suppressant |
| 06/27/2007 | EP1800679A2 Nonsedating A-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione |
| 06/27/2007 | EP1800678A1 Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme |
| 06/27/2007 | EP1800669A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/27/2007 | EP1800666A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 06/27/2007 | EP1799644A1 Lercanidipine salts |
| 06/27/2007 | EP1799268A2 Magnetic particles for therapy and diagnosis |
| 06/27/2007 | EP1799250A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/27/2007 | EP1799245A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
| 06/27/2007 | EP1799229A1 Pulmonary administration of an antithrombotic compound |
| 06/27/2007 | EP1799199A1 Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1525177B1 Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/27/2007 | EP1368312B1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 06/27/2007 | EP1366025B1 Agonists of beta-adrenoreceptors |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition |
| 06/27/2007 | EP1047676B1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 06/27/2007 | CN1989146A Sulfated oligosaccharide derivatives |
| 06/27/2007 | CN1989117A Substituted benzothiazoles |
| 06/27/2007 | CN1988902A Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 06/27/2007 | CN1985972A Method for preventing and treating diseases with serial lingzhigu coix seed granules |
| 06/27/2007 | CN1985965A Medicine for treating coronary heart disease and cerebral thrombus and its preparing method |
| 06/27/2007 | CN1985929A Oral medicine fortreating piles |
| 06/27/2007 | CN1985909A Medicine for hyperlipemia and its production process |
| 06/27/2007 | CN1985908A Blood vessel cleaning tea and its making process |
| 06/27/2007 | CN1985892A Chinese medicine preparation for treating chest obstruction and its preparing process and quality control method |
| 06/27/2007 | CN1985887A Medicine composition for treating cardiac and cerebral vascular diseases |
| 06/27/2007 | CN1985881A Preparing process and application of compound red sage and chuanxiong rhizome oral preparation |
| 06/27/2007 | CN1985866A Application of Chinese medicine composition in treating cardiac and cerebral vascular diseases |
| 06/27/2007 | CN1985857A Externally applied medicine for treating piles and its preparing process and quality detection method |
| 06/27/2007 | CN1985855A Ginkgo health vinegar recipe and preparing method |
| 06/27/2007 | CN1985847A Use of low molecular weight brown algae polyose fulfate in preparing medicine for treating cardiac and cerebral vascular diseases |
| 06/27/2007 | CN1985846A Use of brown algae polyose sulfate in preparing medicine fortreating cardic and cerebral vascular diseases |
| 06/27/2007 | CN1985836A Medicine composition for treating cerebral ischemia |
| 06/27/2007 | CN1985834A Plaster containing Chinese medicine cyclovirobuxine D and its preparing method |
| 06/27/2007 | CN1985833A Use of estrone derivative EA204 in preparing vascular smooth muscle relaxant |